Elegant Business Capital Systems For 2015

Funding Deals

The investment was co-led by OrbiMed and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma). In addition to OrbiMed and Sun Pharma, existing investors 5AM Ventures and Lundbeckfond Ventures participated in the financing. This Series B investment will support the development of the operational and commercial infrastructure to bring Furoscix and the sc2Wear Infusor to market in the United States. "We are very pleased with the strong interest in this financing round from leading life science and strategic corporate investors," said Pieter Muntendam, MD, founder, president

... Read more